Menu Search
Equities

Envista Holdings Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
0HV:STU

Envista Holdings Corp

Actions
  • Price (EUR)24.60
  • Today's Change3.80 / 18.27%
  • Shares traded0.00
  • 1 Year change+18.27%
  • Beta0.9783
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.

  • Revenue in USD (TTM)2.62bn
  • Net income in USD15.30m
  • Incorporated2018
  • Employees12.30k
  • Location
    Envista Holdings Corp200 S. Kraemer Blvd., Bldg. EBREA 92821United StatesUSA
  • Phone+1 (714) 817-5418
  • Fax+1 (302) 655-5049
  • Websitehttps://envistaco.com/en
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		NVST:NYQ since
announced		Transaction
value
Alpha Bio France SASDeal completed23 Jun 202523 Jun 2025Deal completed54.05%--
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.